Why was NINLARO compared to a placebo in TOURMALINE-MM4?

Why was NINLARO compared to a placebo in TOURMALINE-MM4?

Cancer-News

2 months
5 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Meletios Athanasios Dimopoulos @thanosdimop of University Athens School of Medicine answers why ninlaro was compared to a placebo in TOURMALINE-MM4. Dr. Dimopoulous further discusses when the TOURMALINE-MM4 trial results will be presented.

Up Next Autoplay